WilliamGerardPowderlyMD

Infectious Disease • Saint Louis, MO

HIV/AIDS Medicine, Transplant/Immunocompromised States, International Health, Travel & Tropical

Director, Institute for Public Health. Washington University

Join to view full profile

Dr. Powderly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Powderly's full profile

Already have an account?

Office
620 S Taylor Ave
# Dv
Saint Louis, MO 63110
Phone+1 314-362-9098

Fax+1 314-362-9851

Summary

Dr. William Powderly is an infectious disease specialist in Saint Louis, MO. He received his medical degree from University College of Dublin National Univ SOM and has been in practice 38 years. He specializes in hiv/aids medicine, transplant/immunocompromised states, and international health, travel & tropical and is experienced in public health and infectious disease. He has more than 500 publications and over 10000 citings.

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 1983 - 1986
University College of Dublin National Univ SOMClass of 1979, MD

Certifications & Licensure

MO State Medical License 2013 - 2025
Royal College Of Physicians in IrelandInternal Medicine
Royal College of Physicians In IrelandMedicine

Publications & Presentations

PubMed

14 citations
Creation and assessment of a clinical predictive model for candidaemia in patients with candiduria.
Katie Wang, Kevin Hsueh, Ryan Kronen, Charlotte Lin, Ana S. Salazar
Mycoses. 2019-07-01
12 citations
Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With Candida krusei Bloodstream Infections.
Ryan Kronen, Kevin Hsueh, Charlotte Lin, William G. Powderly, Andrej Spec
Open Forum Infectious Diseases. 2018-02-01
41 citations
The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era.
Patrick B Mazi, John M Sahrmann, Margaret A Olsen, Ariella Coler-Reilly, Adriana M Rauseo
Clinical Infectious Diseases. 2023-04-03

Authored Content

Cryptococcal Meningitis and Aids: News from IAS 2021August 2021

Press Mentions

Clinical and Translational Research Receives $61 Million Grant SupportMay 12th, 2022

Grant Support

WU 122: Evaluate Metabolic Effects Of Discontinuation Of Antiretroviral TherapyNational Center For Research Resources2004
Study Of Once-Weekly Alendronate In Hiv-Infected SubjectsNational Center For Research Resources2004
Rosiglitazone &Exercise Training: Effects On Hiv-Infected PeopleNational Center For Research Resources2004
Patient Recruitment &Clinical Management CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2003
Infectious Disease/Basic Microbial Pathogenic MechanismsNational Institute Of Allergy And Infectious Diseases1999–2003
Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–2003
T20 With Abacavir, Amprenavir And Efavirenz In HIVNational Center For Research Resources2000–2002
ACTG A5047:Pharmacokinetic Interactions With Protease Inhibitors &Lipid LoweringNational Center For Research Resources2000–2002
ACTG 400: Phase 2 Trial Of Salvage Antiretroviral Therapies For HIV InfectionNational Center For Research Resources2000–2002
Core--Clinical FacilityNational Institute Of Allergy And Infectious Diseases1998–2002
Diabetes And Lipid Disorders In HIV Infection Treated With Protease InhibitorsNational Center For Research Resources1999
Diabetes And Lipid Disorders In HIV Infected Treated With Protease InhibitorsNational Center For Research Resources1999
Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–1999
Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Core--Clinical FacilityNational Institute Of Allergy And Infectious Diseases1998
Core--Clinical ResearchNational Institute Of Allergy And Infectious Diseases1997
Antiviral Efficacy Pharmacokinetic/Safety Of ABT-538 In HIV Infected PatientsNational Center For Research Resources1996
AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
Trial Of Foscarnet In AIDS Patients With CMV RetinitisNational Center For Research Resources1990
Secondary Prophylaxis Of Pneumocystis Pneumonia In AIDSNational Center For Research Resources1990
Prevention Of Pneumocystis Pneumonia In Advanced HIV InfectionNational Center For Research Resources1990
Phase I Study Of Sg48334 In Patients With AIDS Related ComplexNational Center For Research Resources1990